MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1681/asn.2019101106

Медицинская библиотека · Journal of the American Society of Nephrology : JASN · 2020

Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study.

Ishigami Junichi, Taliercio Jonathan T, Feldman Harold I, Srivastava Anand, Townsend Raymond R, Cohen Debbie L, Horwitz Edward J, Rao Panduranga, Charleston Jeanne, Fink Jeffrey C, Ricardo Ana C, Sondheimer James, Chen Teresa K, Wolf Myles, Isakova Tamara, Appel Lawrence J, Matsushita Kunihiro, CRIC study Investigators

СтатьяПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

BACKGROUND

Risk of infectious disease is increased among individuals with CKD. Fibroblast growth factor 23 (FGF23) is often elevated in CKD, and may impair immune function directly or indirectly through proinflammatory and vitamin D-suppressing pathways. Whether FGF23 is associated with risk of infection has not been evaluated in a CKD population.

METHODS

In 3655 participants of the Chronic Renal Insufficiency Cohort study, we evaluated the association of baseline plasma levels of C-terminal FGF23 with time to first hospitalization with major infection, defined by hospital discharge with a diagnosis code for urinary tract infection, pneumonia, cellulitis/osteomyelitis, or bacteremia/septicemia. Multivariable Cox models were used to estimate hazard ratios (HRs) and adjust for confounding.

RESULTS

During a median follow-up of 6.5 years, 1051 individuals (29%) were hospitalized with major infection. Multivariable Cox analysis indicated a graded increase in the risk of infection with higher levels of FGF23 (HR, 1.51; 95% CI, 1.23 to 1.85 with the highest quartile [≥235.9 RU/ml] versus lowest quartile [<95.3 RU/ml]; HR, 1.26; 95% CI, 1.18 to 1.35 per SD increment in log FGF23). The association was consistent across infection subtypes and demographic and clinical subgroups, and remained significant after additional adjustment for biomarkers of inflammation (IL-6, TNF-α, high-sensitivity C-reactive protein, fibrinogen, and albumin), and bone mineral metabolism (25-hydroxyvitamin D, phosphorus, calcium, and parathyroid hormone). The association was consistent across infection subtypes of urinary tract infection (482 cases), cellulitis/osteomyelitis (422 cases), pneumonia (399 cases), and bacteremia/septicemia (280 cases).

CONCLUSIONS

Among individuals with CKD, higher FGF23 levels were independently and monotonically associated with an increased risk of hospitalization with infection.

Для цитирования: Ishigami Junichi, Taliercio Jonathan T, Feldman Harold I, Srivastava Anand, Townsend Raymond R, Cohen Debbie L, Horwitz Edward J, Rao Panduranga, Charleston Jeanne, Fink Jeffrey C, Ricardo Ana C, Sondheimer James, Chen Teresa K, Wolf Myles, Isakova Tamara, Appel Lawrence J, Matsushita Kunihiro, CRIC study Investigators. Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study.. Journal of the American Society of Nephrology : JASN. 2020. DOI: 10.1681/asn.2019101106.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.